Dynamic of transfer, displacement in motion : Polish poetry on the way to Spain

Adam Zagajewski ma ugruntowaną pozycję w hiszpańskim systemie literackim. Być może jest on najbardziej cenionym twórcą spośród zagranicznych poetów. Jego twórczość stanowi przedmiot odniesienia hiszpańskich poetów, reprezentujących różne pokolenia i kierunki. Artykuł przedstawia mechanizmy, które umożliwiały polskiemu poecie zajęcie centralnej pozycji w nowym systemie, analizuje tło i przebieg tego specyficznego transferu literackiego.Adam Zagajewski is an established figure within the Spanish literary system. He might be the most admired author amongst foreign poets. His oeuvre is a reference point for Spanish poets from various generations and representing diverse literary movements. This article explores the mechanisms, which allowed the Polish poet to claim a central position in the new system and analyses the background as well as the course of this particular literary transfer

Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.

ERBB receptor transmodulation by heterologous G-protein-coupled receptors (GPCR) generates functional diversity in signal transduction. Tachykinins are neuropeptides and proinflammatory cytokines that promote cell survival and cancer progression by activating several GPCRs. In this work, we found that the pain-associated tachykinin Substance P (SP) contributes to persistent transmodulation of the ERBB receptors, EGFR and HER2, in breast cancer, acting to enhance malignancy and therapeutic resistance. SP and its high-affinity receptor NK-1R were highly expressed in HER2(+) primary breast tumors (relative to the luminal and triple-negative subtypes) and were overall correlated with poor prognosis factors. In breast cancer cell lines and primary cultures derived from breast cancer samples, we found that SP could activate HER2. Conversely, RNA interference-mediated attenuation of NK-1R, or its chemical inhibition, or suppression of overall GPCR-mediated signaling, all strongly decreased steady-state expression of EGFR and HER2, establishing that their basal activity relied upon transdirectional activation by GPCR. Thus, SP exposure affected cellular responses to anti-ERBB therapies. Our work reveals an important oncogenic cooperation between NK-1R and HER2, thereby adding a novel link between inflammation and cancer progression that may be targetable by SP antagonists that have been clinically explored

Análisis de la situación de los estudios agronómicos y forestales en Europa. Anexo III: análisis de los estudios europeos

El documento que se presenta es el resultado del análisis de la situación actual en estas ingenierías y del estudio del futuro de las mismas. Todas las propuestas que aquí se hacen se han consensuado en las sesiones del Plenario del grupo de trabajo. Por ello, es justo reconocer la aportación que este trabajo puede suponer a la futura Convergencia Europea en la Educación Superior

FaST-LMM for two-way Epistasis tests on high performance clusters

[EN] We introduce a version of the epistasis test in FaST-LMM for clusters of multithreaded processors. This new software maintains the sensitivity of the original FaST-LMM while delivering acceleration that is close to linear on 12-16 nodes of two recent platforms, with respect to improved implementation of FaST-LMM presented in an earlier work. This efficiency is attained through several enhancements on the original single-node version of FaST-LMM, together with the development of a message passing interface (MPI)-based version that ensures a balanced distribution of the workload as well as a multigraphics processing unit (GPU) module that can exploit the presence of multiple GPUs per node.The researchers from the Universitat Jaume I were supported by projects TIN2014-53495-R and TIN2017-82972-R of the MINECO and FEDER.Martínez, H.; Barrachina, S.; Castillo, M.; Quintana Ortí, ES.; Rambla De Argila, J.; Farre, X.; Navarro, A. (2018). FaST-LMM for two-way Epistasis tests on high performance clusters. Journal of Computational Biology. 25(8):862-870. https://doi.org/10.1089/cmb.2018.0087S86287025

Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area : A Retrospective Cohort Study

Altres ajuts: AstraZeneca/ESR-16-12628Altres ajuts: Applied Research Collaboration East Midlands (ARC EM)Altres ajuts: National Institute for Health Research (NIHR)Altres ajuts: Imperial Biomedical Research Centre (NIHR)The aims of our study was compare adherence measured by the medical possession ratio (MPR), time until discontinuation and describe adverse events after adding a DPP-4i, SGLT-2i, or sulfonylureas (SU) to metformin in a primary care population with insufficient glycemic control. We used routinely-collected health data from the SIDIAP database. The included subjects were matched by propensity score. The follow-up period was up to 24 months or premature discontinuation. The primary outcomes were the percentage of subjects with good adherence, treatment discontinuation and adverse events among treatment groups. The proportion of patients with good adherence (MPR> 0.8) after the addition of DPP-4i, SGLT-2i or SU was 53.6%, 68.7%, and 43.0%, respectively. SGLT-2i users were 1.7 times more likely to achieve good adherence compared with DPP-4i users (odds ratio [OR]:1.72, 98% confidence interval [CI]:1.51, 1.96), and 2.8 times more likely compared with SU users (OR: 0.35, 98% CI: 0.07, 0.29). The discontinuation hazard ratios were 1.43 (98%CI: 1.26; 1.62) and 1.60 (98%CI: 1.42; 1.81) times higher among SGLT-2i and SU users than DPP-4i users during the follow-up period. No differences were observed for adverse events among the treatment groups. In conclusion, in our real-world setting, the combination of SGLT-2i with metformin was associated with better adherence. The mean time until discontinuation was longer in the SGLT-2i group in comparison with the DPP-4i or SU groups

Evolució de la mortalitat a Catalunya, 1983-1998

Mortalitat; Catalunya: Mortality; Catalonia; Mortalidad; CataluñaL’objectiu d’aquesta publicació és posar a disposició dels usuaris un conjunt notable d’informació de la qual es pot fer un ús directe, atès que es presenten diversos indicadors elaborats per al període 1983-1998. Així mateix, conscients que el recull de dades d’aquests anys pot suposar una font d’informació primària valuosa per a posteriors càlculs, segons les necessitats més específiques d’investigadors o professionals sanitaris, s’adjunten a l’annex diverses taules amb dades en nombres absoluts

Impacte de l’edat i les causes de mort en els canvis de l’esperança de vida en néixer: Catalunya, 1987-2002

Mortalitat; Esperança de vida; Catalunya; Mortality; Life Expectancy; Catalonia; Mortalidad; Esperanza de vida; CataluñaEn aquest treball s’analitza l’impacte que han tingut les diferents causes de mort, l’edat i el sexe sobre els canvis observats en l’esperança de vida en néixer, entre diferents períodes. El mètode desenvolupat per Arriaga i utilitzat en aquesta anàlisi permet descompondre els canvis observats entre diferents períodes (o les diferències entre dos territoris) segons els factors que hi han intervingut

GCAT|Panel, a comprehensive structural variant haplotype map of the Iberian population from high-coverage whole-genome sequencing

The combined analysis of haplotype panels with phenotype clinical cohorts is a common approach to explore the genetic architecture of human diseases. However, genetic studies are mainly based on single nucleotide variants (SNVs) and small insertions and deletions (indels). Here, we contribute to fill this gap by generating a dense haplotype map focused on the identification, characterization, and phasing of structural variants (SVs). By integrating multiple variant identification methods and Logistic Regression Models (LRMs), we present a catalogue of 35 431 441 variants, including 89 178 SVs (≥50 bp), 30 325 064 SNVs and 5 017 199 indels, across 785 Illumina high coverage (30x) whole-genomes from the Iberian GCAT Cohort, containing a median of 3.52M SNVs, 606 336 indels and 6393 SVs per individual. The haplotype panel is able to impute up to 14 360 728 SNVs/indels and 23 179 SVs, showing a 2.7-fold increase for SVs compared with available genetic variation panels. The value of this panel for SVs analysis is shown through an imputed rare Alu element located in a new locus associated with Mononeuritis of lower limb, a rare neuromuscular disease. This study represents the first deep characterization of genetic variation within the Iberian population and the first operational haplotype panel to systematically include the SVs into genome-wide genetic studies